#Madrid #Italy #Esaote Group #MyLab C30 #HeartScan Assistant

Esaote Group Unveils Cardiac Innovations at ESC 2025

Esaote Group, a renowned Italian innovator specializing in medical imaging solutions, is set to present groundbreaking advancements in cardiac technologies at the European Society of Cardiology (ESC) Congress 2025. Taking place from August 29 to September 1 at the IFEMA MADRID (Booth A280, Exhibition Hall West), this event gathers prominent leaders and innovators in cardiovascular medicine.

The centerpiece of Esaote's exhibition will be its extensive portfolio of cardiovascular imaging technologies designed to enhance diagnostic accuracy, streamline workflows, and support clinical decision-making throughout the continuum of care. One of the highlights of this year’s presentation will be the introduction of the *MyLab™C30 cardio, an advanced portable ultrasound system tailored specifically for cardiology applications.

Equipped with the largest touchscreen in its class, an intuitive user interface, and advanced AI-driven tools, the MyLab™C30 cardio significantly reduces examination time while ensuring diagnostic confidence—even in the most complex scenarios. Its long battery life and robust performance make it ideal for both routine assessments and emergency situations.

Another exciting feature being unveiled is the HeartScan Assistant, a new AI-powered functionality designed to assist healthcare professionals in acquiring transthoracic echocardiography images. This innovative tool provides real-time AI feedback regarding view classification and image quality, thereby accelerating daily practice for cardiologists—especially beneficial in emergencies and for less experienced clinicians.

In addition to these tools, Esaote will showcase an insightful presentation on hyperdoppler techniques and their clinical applications on Saturday, August 30, from 12:00 PM to 1:30 PM at their booth. This talk aims to explore how force distribution analyses can identify advanced or dysfunctional hearts and monitor the impacts of resynchronization therapies in heart failure patients.

Esaote’s healthcare IT division, Ebit, will also present the latest developments in their Suitestensa CVIS PACS platform, designed for both outpatient and interventional cardiology. This platform integrates AI-driven tools such as fAInd for clinical decision support and ZEfiRO for intelligent workflow orchestration, ensuring smooth integration with advanced tools like CAAS Qardia.

CAAS Qardia, developed by Pie Medical Imaging, part of the Esaote Group, features the upcoming version v2.2 that introduces the Qardia View Classifier, an AI-powered assistant that optimally selects images for standardized measurements, minimizes the need for manual selection, and reduces the time spent navigating through image sets. Additionally, critical echo measurements such as myocardial strain and heart dimensions are now automated. CAAS Qardia* offers both standalone and zero-footprint access via a web browser, expanding its versatility and accessibility.

Esaote Group reaffirms its commitment to advancing cardiovascular diagnostics through innovation, clinical collaboration, and ongoing investments in research and development, aiming to improve patient care and outcomes globally.

FDA pending. Not available for sale in the United States.

Esaote Group stands as a leader in medical imaging, focusing on ultrasound, MRI, and diagnostic process management software. By the end of 2024, the company employed 1,300 people, with half located in Italy. With facilities in Genoa and Florence and dedicated production and research units in Italy and the Netherlands, Esaote's impact spans over 100 countries worldwide. For more information, visit www.esaote.com.